Precision Neuroscience is building a next-generation brain–computer interface (BCI) to heal and empower millions of people living with neurological conditions.

Our first product, Layer 7, is designed to help people with severe paralysis operate digital devices using only their thoughts—opening up new possibilities for daily life. 

Our team brings together experts in neurosurgery, AI and machine learning, microfabrication, electrical engineering, clinical science, and more. We combine deep technical rigor with a people-first mindset to turn breakthrough research into real-world medical solutions.

As a Precision employee, you’ll join one of the fastest-moving and best-capitalized companies in the emerging field of brain–computer interfaces. Since our founding in 2021, we have raised more than $180 million, advanced our technology through validation, and initiated human trials with leading hospitals across the country.

Our Values:

We build for human impact, measuring progress by the lives our work can change.

We do no harm, holding ourselves to the highest standards of safety, integrity, and responsibility. 

We innovate with urgency, because the stakes are high and our users can’t wait. 

We bring sharp minds, open ears, pairing expertise with curiosity, humility, and respect. 

And we lead the way, taking ownership of our work and helping to shape the future of our field.

We are seeking a Vice President of Market Access to build the market access, reimbursement, and commercial infrastructure required to bring our Brain–Computer Interface (BCI) therapy to patients. This role is central to translating breakthrough neurotechnology into real-world clinical adoption by establishing sustainable coverage, coding, payment, and evidence strategies for a Class III neurotechnology device.

This leader will operate at the intersection of neuroscience, clinical evidence, payer economics, and commercial execution, and will lead cross-functionally across market access, reimbursement, marketing, revenue strategy, and commercial operations. This is a rare opportunity to define the go-to-market and access model for a first-in-category BCI platform and to help shape how neurotechnology is adopted, paid for, and scaled in the U.S. healthcare system.

This position will be based in our Manhattan or Santa Clara office, or may be remote. We are unable to consider individuals who are not currently based in the US and legally authorized to work in the US. 

Key Responsibilities

• Lead the end-to-end reimbursement strategy for a novel neurotechnology, encompassing coverage, coding, and payment pathways across CMS and commercial payers, from pre-approval planning through post-market expansion.

• Define pricing and contracting strategies that reflect the clinical, functional, and economic value of a BCI therapy, incorporating health economics, outcomes research, and payer value frameworks.

• Partner closely with clinical, regulatory, and medical affairs teams to shape evidence generation strategies (clinical trials, functional endpoints, RWE, HEOR) that support payer coverage, policy development, and long-term adoption.

• Build and lead the selection and implementation of core market access systems (e.g., CRM, analytics platforms) and establish a policy monitoring and payer analytics capability to inform reimbursement strategy and operations.

• Define and build the field reimbursement and provider support model, enabling neurologists, neurosurgeons, and health systems to navigate coverage, prior authorization, and revenue cycle processes for BCI procedures and devices.

• Manage and integrate external partners, including reimbursement advisors, neurotechnology consultants, and commercial service providers.

Skills, Knowledge & Expertise

• 10+ years of progressive market access leadership experience in medical devices, neurotechnology, biotechnology, or adjacent healthcare sectors, with meaningful exposure to Class III or implantable technologies.

• Strong preference for candidates with experience in neurotechnology, neuromodulation, brain–computer interfaces, implantable neural devices, or advanced neurotherapeutics.

• Deep expertise in market access and reimbursement, including CMS and commercial payer engagement, coding strategy, payment methodologies, and coverage policy development.

• Experience working closely with clinical, scientific, and regulatory teams to translate neuroscience-driven evidence into compelling payer and provider value propositions.

• Experience managing external agencies and negotiating vendor and consulting relationships.

• Strong understanding of the legal, regulatory, and compliance landscape for Class III medical devices and neurotechnology.

• Excellent communication and executive presence, with the ability to influence stakeholders from the Board of Directors to cross-functional scientific and commercial teams.

• Bachelor’s degree required; MBA, PhD, or other advanced degree strongly preferred, particularly in neuroscience, biomedical engineering, or a related field.

We prioritize candidate security. Please be aware that job offers will only come from emails ending with @precisionneuro.io 

Diverse workforces create the best culture, company, and products. We at Precision are committed to an inclusive culture that celebrates the uniqueness and contributions of everyone. As an equal opportunity employer, Precision does not discriminate on the basis of sex, race, religion, national origin, disability status, protected veteran status, or any other characteristic protected by law.

The actual base salary offered is determined by a number of variables, including, as appropriate, the applicant's qualifications for the position, years of relevant experience, distinctive skills, level of education attained, certifications or other professional licenses held, and the location of residence and/or place of employment.

For roles based in Massachusetts: it is unlawful in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment. An employer who violates this law shall be subject to criminal penalties and civil liability.